Mechanistically, METTL16-mediated m6A modification enhances FBXO5 mRNA stability through a post-transcriptional regulatory mechanism, thereby driving its oncogenic functions and facilitating malignant progression in breast cancer [177]. Here, METTL16 is linked to breast cancer.